Skip to main content

Table 2 Measurement items and assessment of study endpoints

From: RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial

Study period

Lead-in period

Treatment period

Follow-up times

1

2

3

4

5

6

Time point

0 Day

24 h

48 h

72 h

96 h

120 h

Case screening

 

History

     

Indicator check

   

Basic information

     

Determine the inclusion

     

Informed content

     

Indicator check

 

Temperature

BP/HR/P/symptoms/signs

Blood routine/Urine routine

    

Liver function/Kidney function

    

Twelve-lead ECG

    

Pathogen test

    

Inflammatory factor test

    

Others

 

randomization

     

Drug distribution

     

Drug recycle/

medication compliance

     

Combined medication

 

AEs

 

Recycle drug

     

Conclusion of Completion of experiment